Specialty

Article

How to stay ahead of a rapidly evolving utilization management landscape

Regulatory pressures and technological advancements are changing utilization management as we know it—here’s what plan sponsors should know.

July 19, 24

Article

How Evernorth helps providers and health systems deliver comprehensive care to patients

Today, health systems are facing a variety of challenges, among them, staffing shortages, rapidly increasing patient demand, and rising costs.

July 11, 24

Article

Leveraging biosimilars to drive savings and support patient access

July 01, 2024

By the end of 2024, 3 FDA-approved biosimilars to Stelara for patients living with inflammatory conditions will be closer to launch, enabling lower total drug spend.

Article

Transforming oncology care through a holistic, patient-centric, and consultative approach

Evernorth Health Services has introduced Evernorth Oncology Benefit Services, which will be available to eligible commercial plan sponsors in 2025, with plans to expand over time.

June 10, 24

Article

Evernorth chief bullish on driving affordability through biosimilars and access through guided care

May 08, 24

Article

Outcomes 2024: How Evernorth manages the drug pipeline today and prepares for tomorrow

May 08, 24